Advertisement
Advertisement
-
GlaxoSmithKline
TOPIC
 / company

GlaxoSmithKline

GlaxoSmithKline
GlaxoSmithKline
The London-based multinational drugmaker, also known as GSK, supplies key products such as vaccines in China, as well as drugs for lung disease and cancer. In 2013, the company was targeted by Chinese authorities over alleged corruption, price-fixing and quality controls.
Chairman / President
Jonathan Symonds
CEO / Managing Director
Dame Emma Natasha Walmsley
CFO / Finance Director
Julie Brown
Industry
Pharmaceutical
Website
gsk.com
Headquarters address
79 New Oxford Street, London, WC1A 1DG, United Kingdom
Stock Code
NYSE:GSK
LSE:GSK
Year founded
2000
In January, AstraZeneca announced plans to invest US$15 billion in China, its second-largest market. Photo: Shutterstock
China’s crackdowns

China charges former AstraZeneca executive – a sign of the times?

Foreign drug makers face pressure in the Chinese market, from tighter regulatory oversight to growing local competition.

Made in China 2025

Chinese biotechs strike a record US$136 billion in out-licensing deals in 2025

China economy

Opinion | How China engineered the rapid rise of its drug innovation industry

videocam
Hong Kong economy

Letters | How Hong Kong can help Chinese drug makers go global

Readers discuss opportunities from medical innovation, tech standards in Hong Kong, and how to stop people treating corals like inanimate objects.

A view of the Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone on April 24. Photo: Edmond So
Hong Kong economy

Digital IP protector from US among 18 firms expanding in Hong Kong under OASES

Vobile among 18 new strategic enterprises that OASES has brought to city.

Hong Kong healthcare and hospitals

Hong Kong to launch collaborative study on long-term effects of shingles vaccine

Study by clinical trial institute, University of Hong Kong and drug giant GlaxoSmithKline will assess potential of heart and dementia protection.

Advertisement
Advertisement
Advertisement
Biomedicine: Companies

China’s Jiangsu Hengrui signs licensing deal with Braveheart Bio for heart drug

The licensing deal for the HRS-1893 innovative drug could fetch as much as US$1.01 billion in milestone payments.

The headquarters of Jiangsu Hengrui Pharmaceutical in Lianyungang Economic and Technological Development Zone, in Jiangsu province. Photo: Costfoto/Future Publishing via Getty Images
Biomedicine: Companies

Chinese pharma firms Hengrui, Hansoh expected to post strong first-half profits

Novel drug roll-outs and revenue from licensing buoy results.

Biomedicine: Companies

Opinion | Biotech successes helping Chinese intellectual property go global

After years of buying licences for foreign-made medicines, Chinese biotech firms are now profiting handsomely from their own innovations.

videocam
Biomedicine: Companies

GSK to pay Hengrui US$12.5 billion for global rights to 12 drug projects

The deal would give GSK the rights to develop the drug for HRS-9821 and 11 preclinical programmes owned by Jiangsu Hengrui Pharmaceuticals.

4
The research lab at the Hengrui Biomedical Industrial Park in Lianyungang in eastern China’s Jiangsu province on December 13, 2021. Photo: Getty Images.
Indonesia

Is Indonesia a ‘guinea pig’ in Bill Gates-backed TB vaccine trial?

The controversy began after President Prabowo Subianto said that Bill Gates was developing a tuberculosis vaccine to be tested in Indonesia.

8
Bill Gates speaks at a Save the Children event on vaccine equity in Germany last year. Photo: AP
United States

FDA approves GSK vaccine to combat meningococcal infections

Meningococcal infections can lead to severe, sometimes deadly, bloodstream infections, and severe swelling in the brain and spinal cord.

Medicine

WHO recommends malaria vaccine for children, to be rolled out next year

The vaccine, developed in the UK, will become available to countries by mid-2024 and doses will cost between US$2 and US$4, said WHO chief Tedros Adhanom Ghebreyesus on Monday.

videocam
Coronavirus pandemic

This man says he can beat Covid-19 with nasal sprays, not needles

Marty Moore, founder of Meissa Vaccines, says nasal sprays could be the future of the fight against Covid-19 and its variants by building better protection where the battle begins.

Marty Moore, the relentlessly upbeat founder of Meissa Vaccines Inc


CREDIT: Bloomberg Businessweek
Coronavirus pandemic

GlaxoSmithKline to manufacture Novavax Covid-19 vaccine in UK

The agreement has the potential to reduce the UK’s reliance on overseas vaccine supplies amid a spat with the EU over exports.

British pharmaceutical firm GlaxoSmithKline’s deal to manufacture the Novavax Covid-19 vaccine will help shore up local supply. Photo: Reuters
Health & Fitness

Chinese drugs firm aims to bring down cost of breast cancer treatment

Shanghai-based Genor Biopharma plans to seek regulatory approval for coprelotamab to be used in China on late-stage breast cancer patients.

videocam
Medicine

In pandemic lesson, drug maker Stada turns to China for supply security

Stada Arzneimittel, owned by private equity firms Bain Capital and Cinven, is turning to China to enhance its supply security and boost sales presence in Asia’s biggest pharmaceutical market.

videocam
Advertisement
Advertisement
Advertisement
Britain

UK watchdog investigates Chinese broadcaster for airing ‘forced confession’

Briton Peter Humphrey and his wife, Yu Yingzeng, were sentenced in China in 2014 for illegally obtaining and selling private records of Chinese citizens.

A screen grab showing Peter Humphrey in the 2014 CCTV broadcast. Photo: CCTV
Disease

Malawi becomes world’s first country to roll out malaria vaccine

After more than three decades in development and almost US$1 billion in investment, the new vaccine began to be distributed in Lilongwe, the nation’s capital.

Corruption in China

China, US and hard cash are emboldening corporate whistle-blowers

videocam
Medicine

U.S. FDA approves GSK next-generation HIV drug dolutegravir

Scanning electromicrograph of an HIV-infected T cell. Photo: NIAID
Wellness

Alibaba partners with GSK for online HPV vaccine service

GSK’s deal with Alibaba comes at a time when China’s health care market is projected to grow at a compound annual rate of 12 per cent by 2020. Photo: Reuters
Corruption in China

US judge dismisses lawsuit against GSK over China whistle-blower

Corruption in China

How Western firms in China can avoid the corruption dragnet

Business Insider

New joint venture to study electronic implants for conditions like diabetes and asthma

Layers of nerve cells in the retina. Photo: Flickr/NIH Image Gallery

Nowhere to hide from bribery laws

At a closed-door trial held last month in Hunan province, one-time high-flying business executive Mark Reilly was handed a three-year suspended prison sentence for his role in the largest corporate bribery scandal involving a foreign firm in China.

GSK China was the subject of a bribery probe. Photo: Kwong Man-ki

Hong Kong hot spot for lawyers

When Cathy Palmer first came to Hong Kong as a US prosecutor more than 20 years ago, she was chasing heroin-smuggling triads who later sent a booby-trapped package to her Brooklyn office.

Multinationals in China on alert in wake of GSK case

In the wake of the Chinese government's punishment of GSK and some of its former senior executives for corruption, multinationals are changing their behaviour and strategies in China, said industry observers.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement